Menu
Henry tells The Wonderbirds about the incredible benefits of all the products you’ll find at Goodbodystore.com and clears up myths related to what you already know about beneficial body oils which help with sleep, relaxation, pain relief, and much more.
Sativa Wellness Group Inc’s (LON:SWEL) Henry Lees-Buckley talks to Proactive London about the latest ruling from the European Court of Justice (ECJ) that CBD is not classified as a narcotic drug and that a French ban on hemp derived CBD contradicts EU law.
London South East invited CEO Henry Lees-Buckley, to give an overview of the Sativa business and the cannabidiol wellness and medicinal markets. If you are interested in finding out more about the CBD sector watch this interview as Henry gives us a very good primer…
Sativa Wellness Group plc (TSX / AQSE:SWEL) CEO Henry Lees-Buckley joins DirectorsTalk in this video interview to discuss the merger of Sativa Group and StillCanna for form Sativa Wellness Group, a true seed to consumer company. Henry explains what the new combined company looks like now, how with the UK FSA Novel Foods process being implemented shortly this will affect the company, traction its Goodbody brand is gaining and capabilities to white or private label products and sell raw CBD ingredients.
Sativa Wellness Group (CSE: SWEI-AQSE: SWEL) CEO Henry Lees-Buckley joined Steve Darling from Proactive to update the merger between Sativa and StillCanna.
Sativa Group PLC (AQSE: SATI) CEO Henry Lees-Buckley joined Steve Darling from Proactive to discuss the company signing a letter of intent with Stillcanna for the companies to come together as one.
Lees-Buckley discusses the reason behind this move and what it does for them in Europe and what the timing of the deal will be.
“Sativa Group (NEX:SATI) CEO Henry Lees-Buckley chats with DirectorsTalk about GoodBody Botanicals being awarded the WH Smith travel business. Henry explains why this is exciting for the company, how its alignment with distributors is paying off, why customers selecting GoodBody Botanicals over the competition, new regulation and how this effects Sativa and what is next for the company.”
“Sativa Group (Nex: SATI) CEO Henry Lees-Buckley dropped into the Vancouver studio of Proactive with news the company has signed a major CBD product listing agreement with WH Smith Travel.
Lees-Buckley talks about just how big that deal is and what he has been hearing from customers about their Goodbody Botanicals.”
Anglo American (LON:AAL) has repeated that Sirius Minerals (LON:SXX) is a “quality” investment which is expected to “fit well” with the FTSE 100 group’s strategy. Anglo, which has made a bid for the firm, says the project in North Yorkshire is attractive in terms of scale, resource life and operating cost profile.
Sativa Group (LON: SATI) CEO Henry Lees-Buckley joined Steve Darling from Proactive Vancouver to discuss the UK’s first listed Cannabis Company. This company focussing on 4 key business areas.
Lee-Buckley talking about those areas and why he feels the UK is the right place at the right time for Sativa.
Proactive London sits down with the newly appointed CEO of Sativa Group PLC (LON:SATI) Henry Lees-Buckley.
Lees-Buckley is a former global executive at Fortune 500 industrial supply firm W. W. Grainger (NYSE:GWW) and joins the group from Uni-Select (TSX:UNS), a Canadian industrial paint seller, where he served as CEO.
Sativa Group PLC‘s (LON:SATI) Geremy Thomas caught up with Proactive London’s Andrew Scott following the opening of their first cannabidiol (CBD) wellness retail outlet in Bath at the weekend.
The Goodbody Wellness store was launched on Friday evening by Crispin Blunt, MP for Reigate and co-chair of the All Party Parliamentary Group for Drug Policy Reform.
Geremy Thomas, founder and chief executive of Sativa Investments PLC (LON:SATI), caught up with Proactive London’s Andrew Scott to discuss the NEX-based medical cannabis investor’s trading and strategic update.
Sativa’s this week unveiled plans to become a first-mover seed-to-consumer business in the UK.
Geremy Thomas, chief executive of Sativa Investments PLC (NEX:SATI), tells Proactive’s Andrew Scott they’ve agreed to buy PhytoVista Laboratories, a UK-based lab that tests cannabis oils and hemp products, for £435,000.
Sativa Investments PLC’s Geremy Thomas tells Proactive that the medicinal cannabis market has seen explosive growth all over the world, particularly in Vancouver, Canada.
He adds that Sativa has a unique position in the UK market that allows UK investors to benefit from companies in regulated markets.
